High materiality7/10
Ascendis Pharma price target lowered to $326 from $328 at Stifel
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Stifel reduces ASND target to 326; current price around 265.32, still signaling upside potential relative to price.
- Target remains above current price, supporting upside.
Key facts
- 01
Target: $326
- 02
Posted price: $265.32
- 03
Analyst firm: Stifel Nicolaus
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.